Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo

BACKGROUND: Lung inflammation is associated with many respiratory conditions. Consequently, anti-inflammatory medications, like glucocorticoids, have become mainstay intrapulmonary therapeutics. However, their effectiveness for treating inflammation occurring in the alveolar regions of the lung is l...

Descripción completa

Detalles Bibliográficos
Autores principales: Baer, Brandon, McCaig, Lynda, Yamashita, Cory, Veldhuizen, Ruud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Pulmonary Drug Delivery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587541/
https://www.ncbi.nlm.nih.gov/pubmed/33106891
http://dx.doi.org/10.1007/s00408-020-00399-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587541/
https://www.ncbi.nlm.nih.gov/pubmed/33106891
http://dx.doi.org/10.1007/s00408-020-00399-2

Ejemplares similares